{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:52:13Z","timestamp":1788515533291,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s40256-024-00629-5","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T11:02:08Z","timestamp":1706785328000},"page":"303-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum Cystatin C as a Risk Factor for Supratherapeutic Digoxin Concentration in Elderly Patients with Heart Failure and Chronic Kidney Disease"],"prefix":"10.1007","volume":"24","author":[{"given":"Jie-Jiu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9467-920X","authenticated-orcid":false,"given":"Tao-Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"issue":"6","key":"629_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger VL. Epidemiology of heart failure. Circ Res. 2013;113(6):646\u201359.","journal-title":"Circ Res"},{"issue":"12","key":"629_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","volume":"63","author":"AP Ambrosy","year":"2014","unstructured":"Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123\u201333.","journal-title":"J Am Coll Cardiol"},{"key":"629_CR3","doi-asserted-by":"crossref","unstructured":"Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993;22(4):955\u201362.","DOI":"10.1016\/0735-1097(93)90403-N"},{"issue":"24","key":"629_CR4","first-page":"1820","volume":"329","author":"RB Devereux","year":"1993","unstructured":"Devereux RB. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med. 1993;329(24):1820.","journal-title":"N Engl J Med"},{"issue":"16","key":"629_CR5","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-239.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"629_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1017\/S1047951115000505","volume":"26","author":"BS Moffett","year":"2016","unstructured":"Moffett BS, Garner A, Zapata T, Orcutt J, Niu M, Lopez KN. Serum digoxin concentrations and clinical signs and symptoms of digoxin toxicity in the paediatric population. Cardiol Young. 2016;26(3):493\u20138.","journal-title":"Cardiol Young"},{"issue":"10","key":"629_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jacc.2017.12.060","volume":"71","author":"RD Lopes","year":"2018","unstructured":"Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, et al. Digoxin and mortality in patients with atrial fibrillation. J Am Coll Cardiol. 2018;71(10):1063\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"629_CR8","doi-asserted-by":"crossref","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10(10):933\u201389.","DOI":"10.1016\/j.ejheart.2008.08.005"},{"issue":"10225","key":"629_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333.","journal-title":"Lancet"},{"issue":"5","key":"629_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/ehjcvp\/pvab030","volume":"7","author":"R Pontremoli","year":"2021","unstructured":"Pontremoli R, Borghi C, Perrone FP. Renal protection in chronic heart failure: focus on sacubitril\/valsartan. Eur Heart J Cardiovasc Pharmacother. 2021;7(5):445\u201352.","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"issue":"10075","key":"629_CR11","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238\u201352.","journal-title":"Lancet"},{"issue":"11","key":"629_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"issue":"1","key":"629_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-197702010-00001","volume":"2","author":"E Iisalo","year":"1977","unstructured":"Iisalo E. Clinical pharmacokinetics of digoxin. Clin Pharmacokinet. 1977;2(1):1\u201316.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"629_CR14","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1373\/clinchem.2007.090027","volume":"53","author":"NG Dodder","year":"2007","unstructured":"Dodder NG, Tai SS, Sniegoski LT, Zhang NF, Welch MJ. Certification of creatinine in a human serum reference material by GC-MS and LC-MS. Clin Chem. 2007;53(9):1694\u20139.","journal-title":"Clin Chem"},{"issue":"11","key":"629_CR15","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1515\/CCLM.2010.318","volume":"48","author":"A Grubb","year":"2010","unstructured":"Grubb A, Blirup-Jensen S, Lindstr\u00f6m V, Schmidt C, Althaus H, Zegers I. First certified reference material for cystatin C in human serum ERM-DA471\/IFCC. Clin Chem Lab Med. 2010;48(11):1619\u201321.","journal-title":"Clin Chem Lab Med"},{"key":"629_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/IJGM.S218393","volume":"12","author":"O Sae-Lim","year":"2019","unstructured":"Sae-Lim O, Doungngern T, Jaisue S, Cheewatanakornkul S, Arunmanakul P, Anutrakulchai S, et al. Prediction of serum digoxin concentration using estimated glomerular filtration rate in Thai population. Int J Gen Med. 2019;12:455\u201363.","journal-title":"Int J Gen Med."},{"issue":"10","key":"629_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s12012-021-09673-y","volume":"21","author":"GN El-Sarnagawy","year":"2021","unstructured":"El-Sarnagawy GN, El Sharkawy SI, Helal NE. Predictive factors for recurrence of serious arrhythmias in patients with acute digoxin poisoning. Cardiovasc Toxicol. 2021;21(10):835\u201347.","journal-title":"Cardiovasc Toxicol"},{"issue":"28","key":"629_CR18","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","volume":"36","author":"M Vamos","year":"2015","unstructured":"Vamos M, Erath JW, Hohnloser SH. Digoxin-associated mortality: a systematic review and meta-analysis of the literature. Eur Heart J. 2015;36(28):1831\u20138.","journal-title":"Eur Heart J"},{"issue":"4","key":"629_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1046\/j.1365-2125.2002.01549.x","volume":"53","author":"S O'Riordan","year":"2002","unstructured":"O\u2019Riordan S, Ouldred E, Brice S, Jackson SH, Swift CG. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. Br J Clin Pharmacol. 2002;53(4):398\u2013402.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"629_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.7150\/ijms.3.92","volume":"3","author":"T Nakamura","year":"2006","unstructured":"Nakamura T, Ioroi T, Sakaeda T, Horinouchi M, Hayashi N, Saito K, et al. Serum cystatin C levels to predict serum concentration of digoxin in Japanese patients. Int J Med Sci. 2006;3(3):92\u20136.","journal-title":"Int J Med Sci"},{"issue":"3","key":"629_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/2000-1967-087","volume":"109","author":"P Hallberg","year":"2004","unstructured":"Hallberg P, Melhus H, Hansson LO, Larsson A. Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment. Ups J Med Sci. 2004;109(3):247\u201353.","journal-title":"Ups J Med Sci."},{"issue":"11","key":"629_CR22","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1177\/0091270007305503","volume":"47","author":"A Garcia","year":"2007","unstructured":"Garcia A, Hermida J, Tutor JC. Estimation of the glomerular filtration rate from serum creatinine and cystatin C with regard to therapeutic digoxin monitoring. J Clin Pharmacol. 2007;47(11):1450\u20135.","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"629_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23427","volume":"34","author":"T \u0160\u00e1lek","year":"2020","unstructured":"\u0160\u00e1lek T, Vodi\u010dka M, G\u0159iva M. Cystatin C may be better than creatinine for digoxin dosing in older adults with atrial fibrillation. J Clin Lab Anal. 2020;34(10): e23427.","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"629_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/08860220701810315","volume":"30","author":"R Hojs","year":"2008","unstructured":"Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease. Ren Fail. 2008;30(2):181\u20136.","journal-title":"Ren Fail"},{"key":"629_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12953-016-0096-7","volume":"14","author":"HN Yassine","year":"2016","unstructured":"Yassine HN, Trenchevska O, Dong Z, Bashawri Y, Koska J, Reaven PD, et al. The association of plasma cystatin C proteoforms with diabetic chronic kidney disease. Proteome Sci. 2016;14:7.","journal-title":"Proteome Sci."},{"issue":"Pt 2","key":"629_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1258\/0004563021901847","volume":"39","author":"DJ Newman","year":"2002","unstructured":"Newman DJ, Cystatin C. Ann Clin Biochem. 2002;39(Pt 2):89\u2013104.","journal-title":"Ann Clin Biochem"},{"issue":"11","key":"629_CR27","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1002\/clc.20465","volume":"32","author":"R Deo","year":"2009","unstructured":"Deo R, Shlipak MG, Ix JH, Ali S, Schiller NB, Whooley MA. Association of cystatin C with ischemia in patients with coronary heart disease. Clin Cardiol. 2009;32(11):E18-22.","journal-title":"Clin Cardiol"},{"issue":"6","key":"629_CR28","first-page":"796","volume":"111","author":"CF Einwoegerer","year":"2018","unstructured":"Einwoegerer CF, Domingueti CP. Association between increased levels of cystatin c and the development of cardiovascular events or mortality: a systematic review and meta-analysis. Arq Bras Cardiol. 2018;111(6):796\u2013807.","journal-title":"Arq Bras Cardiol"},{"key":"629_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/127943","volume":"2014","author":"A Vigil","year":"2014","unstructured":"Vigil A, Cond\u00e9s E, Vigil L, Gallar P, Oliet A, Ortega O, et al. Cystatin C as a predictor of mortality and cardiovascular events in a population with chronic kidney disease. Int J Nephrol. 2014;2014: 127943.","journal-title":"Int J Nephrol"},{"issue":"5","key":"629_CR30","first-page":"404","volume":"19","author":"ZB Ruan","year":"2014","unstructured":"Ruan ZB, Zhu L, Yin YG, Chen GC. Cystatin C, N-terminal probrain natriuretic peptides and outcomes in acute heart failure with acute kidney injury in a 12-month follow-up: Insights into the cardiorenal syndrome. J Res Med Sci. 2014;19(5):404\u20139.","journal-title":"J Res Med Sci"},{"issue":"4","key":"629_CR31","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.kint.2020.06.044","volume":"99","author":"CA White","year":"2021","unstructured":"White CA, Akbari A, Allen C, Day AG, Norman PA, Holland D, et al. Simultaneous glomerular filtration rate determination using inulin, iohexol, and (99m)Tc-DTPA demonstrates the need for customized measurement protocols. Kidney Int. 2021;99(4):957\u201366.","journal-title":"Kidney Int"},{"issue":"3","key":"629_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/ajcn\/37.3.478","volume":"37","author":"SB Heymsfield","year":"1983","unstructured":"Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 1983;37(3):478\u201394.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"629_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4235\/agmr.2018.22.2.73","volume":"22","author":"HC Jang","year":"2018","unstructured":"Jang HC. How to diagnose sarcopenia in Korean older adults? Ann Geriatr Med Res. 2018;22(2):73\u20139.","journal-title":"Ann Geriatr Med Res."},{"key":"629_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.arr.2018.07.005","volume":"47","author":"DJ Wilkinson","year":"2018","unstructured":"Wilkinson DJ, Piasecki M, Atherton PJ. The age-related loss of skeletal muscle mass and function: measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans. Ageing Res Rev. 2018;47:123\u201332.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"629_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cardfail.2020.07.013","volume":"27","author":"JB Ivey-Miranda","year":"2021","unstructured":"Ivey-Miranda JB, Inker LA, Griffin M, Rao V, Maulion C, Turner JM, et al. Cystatin c and muscle mass in patients with heart failure. J Card Fail. 2021;27(1):48\u201356.","journal-title":"J Card Fail"},{"key":"629_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100662","volume":"29\u201330","author":"BJ Nankivell","year":"2020","unstructured":"Nankivell BJ, Nankivell LFJ, Elder GJ, Gruenewald SM. How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy. EClinicalMedicine. 2020;29\u201330: 100662.","journal-title":"EClinicalMedicine."},{"issue":"3","key":"629_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.ajkd.2014.04.010","volume":"64","author":"I Soveri","year":"2014","unstructured":"Soveri I, Berg UB, Bj\u00f6rk J, Elinder CG, Grubb A, Mejare I, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64(3):411\u201324.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"629_CR38","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2215\/CJN.12791019","volume":"15","author":"AS Levey","year":"2020","unstructured":"Levey AS, Titan SM, Powe NR, Coresh J, Inker LA. Kidney disease, race, and GFR estimation. Clin J Am Soc Nephrol. 2020;15(8):1203\u201312.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"629_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","volume":"40","author":"VR Dharnidharka","year":"2002","unstructured":"Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221\u20136.","journal-title":"Am J Kidney Dis"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00629-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-024-00629-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00629-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T16:25:48Z","timestamp":1711556748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-024-00629-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["629"],"URL":"https:\/\/doi.org\/10.1007\/s40256-024-00629-5","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"14 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors did not receive any funding for the development of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"JJL and TTL declare no conflicts of interest in relation to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Institutional Ethics Committee from the First Affiliated Hospital of Guangxi Medical University (no. 2022-KY-E-298).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"J.J.L. and T.T.L. were involved in conception and design of the study. J.J.L. collected data and provided analysis. J.J.L. and T.T.L. wrote the first draft of the manuscript, and all authors gave final approval of the manuscript to be published.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The data supporting the conclusions of this article will be made available by the corresponding authors via email.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}